Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.
Sponsor: Yongquan Shi
Summary
At present, there is still a lack of standard and effective treatment strategies and procedures for radiation intestinal injury. Studies have shown that thalidomide can effectively treat refractory gastrointestinal bleeding caused by vascular malformation. Therefore, The investigators designed a single-center, open-label, randomized controlled study to evaluate the efficacy and safety of thalidomide combined with glutamine in the treatment of radiation intestinal injury.
Official title: Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury: a Single-center, Open-label, Randomized Controlled Study
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2024-09-30
Completion Date
2028-11-01
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
Thalidomide
Patients in thalidomide group took thalidomide orally at a dose of 100mg once a day for 8 weeks.
Glutamine
In the glutamine group, two capsules of glutamine were taken orally 3 times a day for 8 weeks.
Thalidomide+Glutamine
Patients in thalidomide combined with glutamine group took thalidomide orally at a dose of 100mg once a day and two capsules of glutamine were taken orally 3 times a day for 8 weeks.
Locations (1)
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Department of Gastroenterology & Hepatology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Ch
Xi'an, Shaanxi, China